Evaluation of Left Ventricular Diastolic Function in Patients Receiving Doxorubicin.
10.4070/kcj.1985.15.4.573
- Author:
Bang Hun LEE
;
Sang Hack NAM
;
Heon Kil LIM
;
Chung Kyun LEE
- Publication Type:Original Article
- MeSH:
Biopsy;
Doxorubicin*;
Echocardiography;
Electrocardiography;
Follow-Up Studies;
Heart Ventricles;
Hematologic Neoplasms;
Humans;
Radionuclide Angiography;
Retrospective Studies;
Systole
- From:Korean Circulation Journal
1985;15(4):573-579
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Doxorubicin(Adriamycin(R)) is effective in the treatment of various solid tumors and hematologic malignancies. Because of dose-related cardiotoxicity, however, early inappropriate discontinuation of doxorubicin therapy may minimize its therapeutic efficacy in many patients. Consequently, clinically sensitive tests are needed to select patients in whom treatment must be stopped early. Various techniques have been used for early detection of subclinical doxorubicin-induced cardiotoxicity, including electrocardiography, systolic time intervals, echocardiography, radionuclide angiography and endomyocardial biopsies. Most studies of doxorubicin cardiotoxicity have dealt with systolic function of the left ventricle and effects on diastolic function have not been reported. In order to determine whether impaired diastolic function may be an early sign of doxorubicin cardiotoxicity, a retrospective study was performed in 12 patients who had undergone serial radioangiography and were found to have left ventricular ejection fractions(LVEF)> or =55% prior to doxorubicin treatment and during follow-up. Average rapid filling velocity(RFV) and slow filling velocity(SFV) were both significantly reduced after doxorubicin treatment. RFV fell from 5.17+/-1.52 units/second to 4.18+/-0.96(P<0.01) and SFV fell from 2.20+/-1.32 units/second to 1.42+/-0.62(P<0.05). There were no significant changes in filling volume ratio, total diastolic time and diastolic time ratio. Since a change in left ventricular diastolic function can occur before ejection fraction falls to subnormal levels, diastolic function as well as systolic function should be examined in the early detection of doxorubicin cardiotoxicity.
